Endpoints News 2026년 3월 12일 Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
Endpoints News 2026년 2월 27일 Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
Endpoints News 2026년 2월 24일 Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market
Endpoints News 2026년 2월 23일 Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Endpoints News 2026년 2월 9일 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News 2026년 2월 4일 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News 2026년 1월 16일 Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai
Endpoints News 2026년 1월 15일 A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit
Endpoints News 2026년 1월 15일 FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
Endpoints News 2026년 1월 15일 Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
Endpoints News 2026년 1월 12일 #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom